https://scholars.lib.ntu.edu.tw/handle/123456789/568347
標題: | Research priorities for the discovery of a cure for chronic hepatitis B: Report of a workshop | 作者: | Block T.M. Alter H. Brown N. Brownstein A. Brosgart C. Chang K.-M. PEI-JER CHEN Cohen C. El-Serag H. Feld J. Gish R. Glenn J. Greten T.F. Guo J.-T. Hoshida Y. Kowdley K.V. Li W. Lok A.S. McMahon B. Mehta A. Perrillo R. Rice C.M. Rinaudo J. Schinazi R.F. Shetty K. |
關鍵字: | Antiviral therapy; Hepatitis B; Hepatitis D; Hepatocellular carcinoma | 公開日期: | 2018 | 出版社: | Elsevier B.V. | 卷: | 150 | 起(迄)頁: | 93-100 | 來源出版物: | Antiviral Research | 摘要: | In early 2017, the Hepatitis B Foundation invited 30 experts in the fields of hepatitis B and liver cancer research to identify projects they deemed important to the goal of finding a cure for chronic hepatitis B and D and the diseases with which these viral infections are associated. They were also asked to identify general categories of research and to prioritize sub-project topics within those areas. The experts generally agreed on broadly defined areas of research, but there was usually little difference between the highest and lowest scoring projects; for the most part, all programs described in this document were considered valuable and necessary. An executive summary of this discussion was recently published (Alter et al., Hepatology 2017). The present manuscript reports the areas of research identified by the workshop participants, provides a brief rationale for their selection, and attempts to express differences among the priorities assigned to each area of research, when such distinctions were expressed. ? 2017 Baruch S. Blumberg Institute |
URI: | https://www.scopus.com/inward/record.uri?eid=2-s2.0-85038836699&doi=10.1016%2fj.antiviral.2017.12.006&partnerID=40&md5=c74e611cb4dec46a1560ea8c755cf5a7 https://scholars.lib.ntu.edu.tw/handle/123456789/568347 |
ISSN: | 0166-3542 | DOI: | 10.1016/j.antiviral.2017.12.006 | SDG/關鍵字: | antivirus agent; entecavir; hepatitis B antigen; hepatitis B virus X protein; hepatitis B(e) antigen; hepatitis Bc antigen; host factor; lamivudine; nucleotidyltransferase inhibitor; ribonuclease H; tenofovir; unclassified drug; virus DNA; antivirus agent; adaptive immunity; antiviral therapy; chronic hepatitis B; Conference Paper; delta agent hepatitis; human; innate immunity; liver cell carcinoma; liver cirrhosis; nonhuman; priority journal; virology; chronic hepatitis B; drug effect; Hepatitis B virus; research; virology; Antiviral Agents; Hepatitis B virus; Hepatitis B, Chronic; Humans; Research |
顯示於: | 臨床醫學研究所 |
在 IR 系統中的文件,除了特別指名其著作權條款之外,均受到著作權保護,並且保留所有的權利。